Understanding The Difference Between Small-Molecule Drugs And Biotherapeutics

Expert Forum

Your registration was successful, so you can now watch and attend the on-demand presentation.

If you know a colleague who would benefit from this presentation, use the form to invite them.

After watching the presentation(s), please take a moment to share your extremely valuable insights. It will only take a few minutes.

Start the Survey

Understanding the Differences Between Small-Molecule Drugs and Biotherapeutics: An OverviewPresentation by Dr. Michael Dong

Synthetic-Biologics Fusion Cuisine: Innovation in Analytical Characterisation of Novel Drug ModalitiesPresentation by Bingchuan Wei, Ph.D.

Expert Forum Panel Discussion

Presenters / Panellists

Dr. Michael Dong Principal Consultant MWD Consulting (USA) Dr. Michael W. Dong is a principal consultant at MWD Consulting, focusing on consulting and training services on HPLC, pharmaceutical analysis, and drug quality. He was formerly a Senior Scientist in Analytical Chemistry and Quality Control at Genentech, a Research Fellow at Purdue Pharma, a Senior Staff Scientist at Applied Biosystems/Perkin-Elmer, and a section head at Celanese Research Company. He holds a Ph.D. in Analytical Chemistry from the City University of New York. He has 130+ publications and five books, including a bestselling book on chromatography (HPLC and UHPLC for Practicing Scientists, 2nd Ed., Wiley, 2019). He is an advisory board member of LCGC magazine.

Dr. Bingchuan Wei, MBA Senior Principal Scientist Genentech (USA) Bingchuan worked on the analytical development and characterization of various drug modalities including both synthetic and biologics from early-stage discovery through to marketed products for 15 years. His scientific research is centered on leveraging advanced analytical technologies in drug development, understanding the structural-functional relationship of therapeutics, and fostering entrepreneurial spirit in the biopharmaceutical industry. He has a PhD in analytical chemistry from Purdue University, MBA from Penn State University and BS in chemistry and mathematics from Peking University.

Dr. Jennifer Rea Technical Development Staff Scientist Genentech (USA) Jennifer Rea has been in Large Molecule Analytical Development at Roche/Genentech since 2009. Including industry internships and academic experience, she has over 20 years of biotechnology experience in bioprocessing and analytical development, with end-to-end drug development experience from early stage to launch.

Moderators

Prof. Dr. Cari Sänger-van de Griend Scientific Director BioQC Expert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing.

Dr. Ewoud van Tricht Scientific Director BioQC Expert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.

Brought to you by:

Ask a Question

Join the conversation (or start a discussion) on the BioQC User Community.

Contact Us

If you have any questions about the event, don’t hesitate to get in touch with the BioQC Team: Feedback & General Enquiry